Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Late Breaking Poster Session - Late Breaking Poster Session
  • Late Breaking Poster Session
  • Share Icon
    Bookmark Icon
  • 2865-LB - ATR-258, a GRK2-Biased ß2AR Modulator, Mitigates Worsening of Insulin Resistance in Type 2 Diabetes after Metformin Withdrawal [Board No. 2865]
    • Schedule
    Notes
  • Poster Hall (Halls D-E)
    2865-LB
    Set Timezone

M.Bokhari: Employee; Current; Atrogi. E.Rollman waara: Employee; Current; Atrogi AB. J.De jong: Employee; Ended; Atrogi. A.Kalinovich: Employee; Current; Atrogi AB. N.Dehvari: Employee; Current; Atrogi AB. T.Bengtsson: Consultant; Current; Insulife AS, Other - Founder; Current; Atrogi AB, Sigrid Therapeutics AB, TBRC research and Development AB.
Type
Main Session